Vascular Biology |
From the Department of Applied Genetics (M.Y., T.S., H.I., Y.Y.) and Department of Medicine (T.S., H.I.., F.N.), Tokyo Medical and Dental University; and the Cardiovascular Research Center, Massachusetts General Hospital (R.E.G., A.R.), and Vascular Research Division, Department of Pathology, Brigham and Womens Hospital, Harvard Medical School (M.A.G.), Boston, Mass.
Correspondence to Masayuki Yoshida, MD, Department of Applied Genetics, Tokyo Medical and Dental University, 1-5-45, Yushima Bldg D-621, Bunkyo-ku, Tokyo 113-8510, Japan. E-mail masamgen{at}tmd.ac.jp
Abstract3-Hydroxy-3-methylglutaryl coenzyme A reductase inhibitors, or statins, have been reported to exert actions independent of their lipid-lowering effects. To critically assess the effects of statins on monocyteendothelial cell interactions, we used an in vitro model that mimicked physiological flow conditions. Monocytic U937 cells were incubated in the presence of cerivastatin for 48 hours. Adhesive interactions of statin-treated U937 cells were then analyzed by use of activated (interleukin-1ß 10 U/mL, 4 hours) human umbilical vein endothelial cells in an in vitro flow apparatus. Flow cytometric analysis of adhesion molecules and measurement of F-actin content in U937 cells were performed before and after statin treatment. Preincubation with cerivastatin significantly decreased U937 firm adhesion to activated human umbilical vein endothelial cells, whereas U937 rolling was not decreased. Fluorescence-activated cell sorter analysis revealed downregulation of U937 surface expression of CD11a, CD18, and VLA4 after statin treatment. Cerivastatin significantly reduced F-actin content in U937 cells and inhibited RhoA translocation, whereas preincubation with C3 exoenzyme reduced U937 adhesion under flow. Cerivastatin reduces monocyte adhesion to vascular endothelium under physiological flow conditions via downregulation of integrin adhesion molecules and inhibition of actin polymerization via RhoA inactivation. Our findings have important implications for the lipid-independent effects of statins.
Key Words: HMG-CoA reductase inhibitor adhesion molecules monocytes atherosclerosis
Related Article:
Arterioscler. Thromb. Vasc. Biol. 2001 21: 1256-1258.
This article has been cited by other articles:
![]() |
F. Montecucco, F. Burger, G. Pelli, N. K. Poku, C. Berlier, S. Steffens, and F. Mach Statins inhibit C-reactive protein-induced chemokine secretion, ICAM-1 upregulation and chemotaxis in adherent human monocytes Rheumatology, March 1, 2009; 48(3): 233 - 242. [Abstract] [Full Text] [PDF] |
||||
![]() |
A. Kawakami, M. Osaka, M. Aikawa, S. Uematsu, S. Akira, P. Libby, K. Shimokado, F. M. Sacks, and M. Yoshida Toll-Like Receptor 2 Mediates Apolipoprotein CIII-Induced Monocyte Activation Circ. Res., December 5, 2008; 103(12): 1402 - 1409. [Abstract] [Full Text] [PDF] |
||||
![]() |
T. T. G. Ho, S. D. Merajver, C. M. Lapiere, B. V. Nusgens, and C. F. Deroanne RhoA-GDP Regulates RhoB Protein Stability: POTENTIAL INVOLVEMENT OF RhoGDI{alpha} J. Biol. Chem., August 1, 2008; 283(31): 21588 - 21598. [Abstract] [Full Text] [PDF] |
||||
![]() |
T. T. Tuomisto, H. Lumivuori, E. Kansanen, S.-K. Hakkinen, M. P. Turunen, J. V. van Thienen, A. J. Horrevoets, A.-L. Levonen, and S. Yla-Herttuala Simvastatin has an anti-inflammatory effect on macrophages via upregulation of an atheroprotective transcription factor, Kruppel-like factor 2 Cardiovasc Res, April 1, 2008; 78(1): 175 - 184. [Abstract] [Full Text] [PDF] |
||||
![]() |
F. Gao, L. Linhartova, A. McD. Johnston, and D. R. Thickett Statins and sepsis Br. J. Anaesth., March 1, 2008; 100(3): 288 - 298. [Abstract] [Full Text] [PDF] |
||||
![]() |
A. Tanimoto, Y. Murata, K.-Y. Wang, M. Tsutsui, K. Kohno, and Y. Sasaguri Monocyte Chemoattractant Protein-1 Expression Is Enhanced by Granulocyte-Macrophage Colony-stimulating Factor via Jak2-Stat5 Signaling and Inhibited by Atorvastatin in Human Monocytic U937 Cells J. Biol. Chem., February 22, 2008; 283(8): 4643 - 4651. [Abstract] [Full Text] [PDF] |
||||
![]() |
C. Kojima, A. Kawakami, T. Takei, K. Nitta, and M. Yoshida Angiotensin-Converting Enzyme Inhibitor Attenuates Monocyte Adhesion to Vascular Endothelium through Modulation of Intracellular Zinc J. Pharmacol. Exp. Ther., December 1, 2007; 323(3): 855 - 860. [Abstract] [Full Text] [PDF] |
||||
![]() |
V. M. Campese and J. Park HMG-CoA Reductase Inhibitors and Renal Function Clin. J. Am. Soc. Nephrol., November 1, 2007; 2(6): 1100 - 1103. [Full Text] [PDF] |
||||
![]() |
T. Rydgren, O. Vaarala, and S. Sandler Simvastatin Protects against Multiple Low-Dose Streptozotocin-Induced Type 1 Diabetes in CD-1 Mice and Recurrence of Disease in Nonobese Diabetic Mice J. Pharmacol. Exp. Ther., October 1, 2007; 323(1): 180 - 185. [Abstract] [Full Text] [PDF] |
||||
![]() |
M.W. Merx and C. Weber Sepsis and the Heart Circulation, August 14, 2007; 116(7): 793 - 802. [Abstract] [Full Text] [PDF] |
||||
![]() |
M.-H. Lee, Y. S. Cho, and Y.-M. Han Simvastatin Suppresses Self-Renewal of Mouse Embryonic Stem Cells by Inhibiting RhoA Geranylgeranylation Stem Cells, July 1, 2007; 25(7): 1654 - 1663. [Abstract] [Full Text] [PDF] |
||||
![]() |
A. Kawakami, M. Aikawa, N. Nitta, M. Yoshida, P. Libby, and F. M. Sacks Apolipoprotein CIII-Induced THP-1 Cell Adhesion to Endothelial Cells Involves Pertussis Toxin-Sensitive G Protein- and Protein Kinase C{alpha}-Mediated Nuclear Factor-{kappa}B Activation Arterioscler. Thromb. Vasc. Biol., January 1, 2007; 27(1): 219 - 225. [Abstract] [Full Text] [PDF] |
||||
![]() |
A. Kawakami, M. Aikawa, P. Alcaide, F. W. Luscinskas, P. Libby, and F. M. Sacks Apolipoprotein CIII Induces Expression of Vascular Cell Adhesion Molecule-1 in Vascular Endothelial Cells and Increases Adhesion of Monocytic Cells Circulation, August 15, 2006; 114(7): 681 - 687. [Abstract] [Full Text] [PDF] |
||||
![]() |
A. Kawakami, M. Aikawa, P. Libby, P. Alcaide, F. W. Luscinskas, and F. M. Sacks Apolipoprotein CIII in Apolipoprotein B Lipoproteins Enhances the Adhesion of Human Monocytic Cells to Endothelial Cells Circulation, February 7, 2006; 113(5): 691 - 700. [Abstract] [Full Text] [PDF] |
||||
![]() |
M. W. Merx, E. A. Liehn, J. Graf, A. van de Sandt, M. Schaltenbrand, J. Schrader, P. Hanrath, and C. Weber Statin Treatment After Onset of Sepsis in a Murine Model Improves Survival Circulation, July 5, 2005; 112(1): 117 - 124. [Abstract] [Full Text] [PDF] |
||||
![]() |
M. B. Fessler, S. K. Young, S. Jeyaseelan, J. G. Lieber, P. G. Arndt, J. A. Nick, and G. S. Worthen A Role for Hydroxy-Methylglutaryl Coenzyme A Reductase in Pulmonary Inflammation and Host Defense Am. J. Respir. Crit. Care Med., March 15, 2005; 171(6): 606 - 615. [Abstract] [Full Text] [PDF] |
||||
![]() |
V. M. Campese, M. K. Nadim, and M. Epstein Are 3-Hydroxy-3-Methylglutaryl-CoA Reductase Inhibitors Renoprotective? J. Am. Soc. Nephrol., March 1, 2005; 16(3_suppl_1): S11 - S17. [Abstract] [Full Text] [PDF] |
||||
![]() |
A. Kawakami, M. Tani, T. Chiba, K. Yui, S. Shinozaki, K. Nakajima, A. Tanaka, K. Shimokado, and M. Yoshida Pitavastatin Inhibits Remnant Lipoprotein-Induced Macrophage Foam Cell Formation Through ApoB48 Receptor-Dependent Mechanism Arterioscler. Thromb. Vasc. Biol., February 1, 2005; 25(2): 424 - 429. [Abstract] [Full Text] [PDF] |
||||
![]() |
L. Verschuren, R. Kleemann, E. H. Offerman, A. J. Szalai, S. J. Emeis, H. M. G. Princen, and T. Kooistra Effect of Low Dose Atorvastatin Versus Diet-Induced Cholesterol Lowering on Atherosclerotic Lesion Progression and Inflammation in Apolipoprotein E*3-Leiden Transgenic Mice Arterioscler. Thromb. Vasc. Biol., January 1, 2005; 25(1): 161 - 167. [Abstract] [Full Text] [PDF] |
||||
![]() |
R. Gotoh, J.-i. Suzuki, H. Kosuge, T. Kakuta, S. Sakamoto, M. Yoshida, and M. Isobe E-Selectin Blockade Decreases Adventitial Inflammation and Attenuates Intimal Hyperplasia in Rat Carotid Arteries After Balloon Injury Arterioscler. Thromb. Vasc. Biol., November 1, 2004; 24(11): 2063 - 2068. [Abstract] [Full Text] [PDF] |
||||
![]() |
I. Cicha, N. Schneiderhan-Marra, A. Yilmaz, C. D. Garlichs, and M. Goppelt-Struebe Monitoring the Cellular Effects of HMG-CoA Reductase Inhibitors In Vitro and Ex Vivo Arterioscler. Thromb. Vasc. Biol., November 1, 2004; 24(11): 2046 - 2050. [Abstract] [Full Text] [PDF] |
||||
![]() |
U. Schonbeck and P. Libby Inflammation, Immunity, and HMG-CoA Reductase Inhibitors: Statins as Antiinflammatory Agents? Circulation, June 1, 2004; 109(21_suppl_1): II-18 - II-26. [Abstract] [Full Text] [PDF] |
||||
![]() |
S. Miyahara, J. Kiryu, K. Yamashiro, K. Miyamoto, F. Hirose, H. Tamura, H. Katsuta, K. Nishijima, A. Tsujikawa, and Y. Honda Simvastatin Inhibits Leukocyte Accumulation and Vascular Permeability in the Retinas of Rats with Streptozotocin-Induced Diabetes Am. J. Pathol., May 1, 2004; 164(5): 1697 - 1706. [Abstract] [Full Text] [PDF] |
||||
![]() |
H. Honing, T. K. van den Berg, S. M. A. van der Pol, C. D. Dijkstra, R. A. van der Kammen, J. G. Collard, and H. E. de Vries RhoA activation promotes transendothelial migration of monocytes via ROCK J. Leukoc. Biol., March 1, 2004; 75(3): 523 - 528. [Abstract] [Full Text] [PDF] |
||||
![]() |
T. T. Tuomisto, A. Korkeela, J. Rutanen, H. Viita, J. H. Brasen, M. S. Riekkinen, T. T. Rissanen, K. Karkola, Z. Kiraly, K. Kolble, et al. Gene Expression in Macrophage-Rich Inflammatory Cell Infiltrates in Human Atherosclerotic Lesions as Studied by Laser Microdissection and DNA Array: Overexpression of HMG-CoA Reductase, Colony Stimulating Factor Receptors, CD11A/CD18 Integrins, and Interleukin Receptors Arterioscler. Thromb. Vasc. Biol., December 1, 2003; 23(12): 2235 - 2240. [Abstract] [Full Text] [PDF] |
||||
![]() |
S. Fujiyama, K. Amano, K. Uehira, M. Yoshida, Y. Nishiwaki, Y. Nozawa, D. Jin, S. Takai, M. Miyazaki, K. Egashira, et al. Bone Marrow Monocyte Lineage Cells Adhere on Injured Endothelium in a Monocyte Chemoattractant Protein-1-Dependent Manner and Accelerate Reendothelialization as Endothelial Progenitor Cells Circ. Res., November 14, 2003; 93(10): 980 - 989. [Abstract] [Full Text] [PDF] |
||||
![]() |
R. Kleemann, H. M.G. Princen, J. J. Emeis, J. W. Jukema, R. D. Fontijn, A. J.G. Horrevoets, T. Kooistra, and L. M. Havekes Rosuvastatin Reduces Atherosclerosis Development Beyond and Independent of Its Plasma Cholesterol-Lowering Effect in APOE*3-Leiden Transgenic Mice: Evidence for Antiinflammatory Effects of Rosuvastatin Circulation, September 16, 2003; 108(11): 1368 - 1374. [Abstract] [Full Text] [PDF] |
||||
![]() |
J. B. Rice, L. L. Stoll, W.-G. Li, G. M. Denning, J. Weydert, E. Charipar, W. E. Richenbacher, F. J. Miller Jr, and N. L. Weintraub Low-Level Endotoxin Induces Potent Inflammatory Activation of Human Blood Vessels: Inhibition by Statins Arterioscler. Thromb. Vasc. Biol., September 1, 2003; 23(9): 1576 - 1582. [Abstract] [Full Text] [PDF] |
||||
![]() |
T. Yu, I. Morita, K. Shimokado, T. Iwai, and M. Yoshida Amlodipine Modulates THP-1 Cell Adhesion to Vascular Endothelium via Inhibition of Protein Kinase C Signal Transduction Hypertension, September 1, 2003; 42(3): 329 - 334. [Abstract] [Full Text] [PDF] |
||||
![]() |
T. Waehre, J. K. Damas, L. Gullestad, A. M. Holm, T. R. Pedersen, K. E. Arnesen, H. Torsvik, S. S. Froland, A. G. Semb, and P.a. Aukrust Hydroxymethylglutaryl coenzyme a reductase inhibitors down-regulate chemokines and chemokine receptors in patients with coronary artery disease J. Am. Coll. Cardiol., May 7, 2003; 41(9): 1460 - 1467. [Abstract] [Full Text] [PDF] |
||||
![]() |
S. Wolfrum, K. S. Jensen, and J. K. Liao Endothelium-Dependent Effects of Statins Arterioscler. Thromb. Vasc. Biol., May 1, 2003; 23(5): 729 - 736. [Abstract] [Full Text] [PDF] |
||||
![]() |
P.O Bonetti, L.O Lerman, C Napoli, and A Lerman Statin effects beyond lipid lowering--are they clinically relevant? Eur. Heart J., February 1, 2003; 24(3): 225 - 248. [Full Text] [PDF] |
||||
![]() |
C. Kluft, R. Kleemann, and M.P.M. de Maat How best to counteract the enemies? By controlling inflammation in the coronary circulation Eur. Heart J. Suppl., November 1, 2002; 4(suppl_G): G53 - G65. [Abstract] [PDF] |
||||
![]() |
A. H. Wagner, M. Gebauer, B. Guldenzoph, and M. Hecker 3-Hydroxy-3-Methylglutaryl Coenzyme A Reductase-Independent Inhibition of CD40 Expression by Atorvastatin in Human Endothelial Cells Arterioscler. Thromb. Vasc. Biol., November 1, 2002; 22(11): 1784 - 1789. [Abstract] [Full Text] [PDF] |
||||
![]() |
A. Kawakami, A. Tanaka, K. Nakajima, K. Shimokado, and M. Yoshida Atorvastatin Attenuates Remnant Lipoprotein-Induced Monocyte Adhesion to Vascular Endothelium Under Flow Conditions Circ. Res., August 9, 2002; 91(3): 263 - 271. [Abstract] [Full Text] [PDF] |
||||
![]() |
R. Baetta, M. Camera, C. Comparato, C. Altana, M. D. Ezekowitz, and E. Tremoli Fluvastatin Reduces Tissue Factor Expression and Macrophage Accumulation in Carotid Lesions of Cholesterol-Fed Rabbits in the Absence of Lipid Lowering Arterioscler. Thromb. Vasc. Biol., April 1, 2002; 22(4): 692 - 698. [Abstract] [Full Text] [PDF] |
||||
![]() |
S. Ledoux, D. Laouari, M. Essig, I. Runembert, G. Trugnan, J.B. Michel, and G. Friedlander Lovastatin Enhances Ecto-5'-Nucleotidase Activity and Cell Surface Expression in Endothelial Cells: Implication of Rho-Family GTPases Circ. Res., March 8, 2002; 90(4): 420 - 427. [Abstract] [Full Text] [PDF] |
||||
![]() |
S. J Miller Emerging mechanisms for secondary cardioprotective effects of statins Cardiovasc Res, October 1, 2001; 52(1): 5 - 7. [Full Text] [PDF] |
||||
![]() |
B. R. Kwak and F. Mach Statins Inhibit Leukocyte Recruitment: New Evidence for Their Anti-Inflammatory Properties Arterioscler. Thromb. Vasc. Biol., August 1, 2001; 21(8): 1256 - 1258. [Full Text] [PDF] |
||||
![]() |
S. Ledoux, D. Laouari, M. Essig, I. Runembert, G. Trugnan, J.B. Michel, and G. Friedlander Lovastatin Enhances Ecto-5'-Nucleotidase Activity and Cell Surface Expression in Endothelial Cells: Implication of Rho-Family GTPases Circ. Res., March 8, 2002; 90(4): 420 - 427. [Abstract] [Full Text] [PDF] |
||||
![]() |
R. Baetta, M. Camera, C. Comparato, C. Altana, M. D. Ezekowitz, and E. Tremoli Fluvastatin Reduces Tissue Factor Expression and Macrophage Accumulation in Carotid Lesions of Cholesterol-Fed Rabbits in the Absence of Lipid Lowering Arterioscler. Thromb. Vasc. Biol., April 1, 2002; 22(4): 692 - 698. [Abstract] [Full Text] [PDF] |
||||
|
ATVB Home | Subscriptions | Archives | Feedback | Authors | Help | AHA Journals Home | Search Copyright © 2001 American Heart Association, Inc. All rights reserved. Unauthorized use prohibited. |